We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$33.1B
AUM Growth
-$360M
Cap. Flow
-$2.85B
Cap. Flow %
-8.61%
Top 10 Hldgs %
8.91%
Holding
2,770
New
218
Increased
1,085
Reduced
860
Closed
222

Sector Composition

Rank Sector Weight
1 Healthcare 14.21%
2 Technology 12.4%
3 Financials 11.14%
4 Consumer Discretionary 9.27%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAS
2151
DELISTED
RAIT Financial Trust
RAS
$302K ﹤0.01%
35,583
-17,100
-32% -$143K
JTD
2152
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$301K ﹤0.01%
+19,693
New +$299K
AGD
2153
abrdn Global Dynamic Dividend Fund
AGD
$323M
$300K ﹤0.01%
+29,959
New +$296K
CPSS icon
2154
Consumer Portfolio Services
CPSS
$203M
$297K ﹤0.01%
43,400
TGTX icon
2155
TG Therapeutics
TGTX
$7.49B
$297K ﹤0.01%
43,100
CNQ icon
2156
Canadian Natural Resources
CNQ
$97.2B
$295K ﹤0.01%
15,928
-64,125
-80% -$1.08M
ADX icon
2157
Adams Diversified Equity Fund
ADX
$3.22B
$294K ﹤0.01%
+22,681
New +$290K
OSIR
2158
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$294K ﹤0.01%
22,372
MGRC icon
2159
McGrath RentCorp
MGRC
$2.93B
$293K ﹤0.01%
8,383
DRTX
2160
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$291K ﹤0.01%
+21,600
New +$283K
FHY
2161
DELISTED
First Trust Strategic High
FHY
$291K ﹤0.01%
18,296
+7,515
+70% +$118K
RXII
2162
DELISTED
GALENA BIOPHARMA INC COM
RXII
$290K ﹤0.01%
115,800
+103,600
+849% +$259K
NAC icon
2163
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
$289K ﹤0.01%
20,842
-511
-2% -$6.94K
JLA
2164
DELISTED
NUVEEN EQUITY PREMIUM ADVANTAGE FUND
JLA
$289K ﹤0.01%
22,775
-53,392
-70% -$679K
IPGP icon
2165
IPG Photonics
IPGP
$3.7B
$287K ﹤0.01%
4,033
-4,500
-53% -$316K
MTH icon
2166
Meritage Homes
MTH
$4.69B
$287K ﹤0.01%
13,696
BDSI
2167
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$287K ﹤0.01%
+34,000
New +$274K
RGP icon
2168
Resources Connection
RGP
$148M
$286K ﹤0.01%
20,300
-73,600
-78% -$1.04M
OME
2169
DELISTED
Omega Protein
OME
$286K ﹤0.01%
23,734
PFBC icon
2170
Preferred Bank
PFBC
$1.24B
$284K ﹤0.01%
+10,952
New +$249K
RUSHA icon
2171
Rush Enterprises Class A
RUSHA
$6.24B
$284K ﹤0.01%
19,679
PSUN
2172
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$284K ﹤0.01%
95,697
-1,884
-2% -$5.51K
ACTA
2173
DELISTED
Actua Corp
ACTA
$282K ﹤0.01%
+13,800
New +$272K
APU
2174
DELISTED
AmeriGas Partners, L.P.
APU
$281K ﹤0.01%
6,652
SABA
2175
Saba Capital Income & Opportunities Fund II
SABA
$223M
$280K ﹤0.01%
+17,440
New +$275K

Similar funds

AQR Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, AQR Capital Management held 2,770 positions worth $33.1B, down 1.1% from $33.5B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

AQR Capital Management withdrew a net $2.85B in Q1 2014, closing 222 positions and reducing 860 holdings. Its most notable exit was LyondellBasell Industries, an estimated $286M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, AQR Capital Management opened a new position in RIVERBED TECHNOLOGY, INC COM worth $76.5M.

  • AQR Capital Management's largest Q1 2014 buy was RIVERBED TECHNOLOGY, INC COM: 3,882,944 shares worth $76.5M.
  • AQR Capital Management added most to BEAM INC COM STK (DE) in Q1 2014, an estimated $208M increase.
  • AQR Capital Management's biggest Q1 2014 reduction was Citigroup, cutting an estimated $89.3M.
  • AQR Capital Management fully exited LyondellBasell Industries in Q1 2014, selling an estimated $286M.
  • AQR Capital Management's ten largest holdings make up 8.9% of its $33.1B portfolio in Q1 2014.
  • AQR Capital Management opened 218 new positions and closed 222 in Q1 2014.
  • AQR Capital Management's portfolio value fell 1.1% quarter-over-quarter to $33.1B.

Based on AQR Capital Management's 13F filing for Q1 2014, filed 15 May 2014.